Prime Minister Narendra Modi on Thursday celebrated the completion of the Genome India Project, describing it as a “historic step in the world of research.” In a video address to the nation, he highlighted the project’s significance in advancing biotechnology and transforming public health in India.
“Five years ago, the Genome India Project was approved. Despite the challenges posed by Covid-19, our scientists have completed the project,” Modi said. The initiative, involving over 20 premier research institutions, has successfully sequenced 10,000 genomes. The data is now securely stored at the Indian Biological Data Centre for use by researchers.
The Prime Minister emphasized the project’s potential impact, stating, “The Genome India Project is an important milestone of the biotechnology revolution. We have been successful in creating a diverse genetic resource. This data will help scholars and scientists understand the genetic landscape of India.”
He further noted that the project would revolutionize public health by enabling targeted clinical interventions and advancing precision medicine. Modi also underscored the broader implications of the achievement, linking it to India’s rise as a global pharma hub. “The world is looking to India for solutions to global problems,” he said, adding that the nation’s bioeconomy has grown from $10 billion in 2014 to over $150 billion today.
What is Genome India Project?
Launched in January 2020 and funded by the Department of Biotechnology, the Genome India Project aims to decode the genetic diversity of India’s population through large-scale genome sequencing.
Key achievements includes:
Genome sequencing of 10,000 individuals: The project successfully sequenced genomes of 10,074 samples, covering 99 ethnic groups.
Creation of a genetic database: Data is securely stored at the Indian Biological Data Centre and will serve as a reference for researchers.
Genetic insights for public health: The study revealed unique genetic variations, some with clinical significance, paving the way for precision medicine.
Sample collection milestones: Over 19,000 blood samples have been collected, exceeding the initial target, and stored in the GenomeIndia Biobank for future research.
Phase 1 analysis: Detailed quality checks and joint genotyping of 5,750 samples have uncovered rare genetic variations unique to Indian populations.
(With inputs from TOI)